Skip to main content
logo
Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.75
-1.90 (-7.13%)
May 4, 2026, 5:29 PM CET

Xspray Pharma AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
1.12.47----
Revenue
1.12.47----
Revenue Growth (YoY)
-42.72%-----
Gross Profit
1.12.47----
Selling, General & Admin
145.08151.1203.88169.57109.658.38
Research & Development
7.9510.7579.3640.2622.2238.57
Other Operating Expenses
-0.59-0.25--29.06-0.44-
Operating Expenses
152.44161.6283.24180.77131.3896.95
Operating Income
-151.34-159.13-283.24-180.77-131.38-96.95
Interest Expense
-17.32-16.85-1.93-0.68-0.01-0
Interest & Investment Income
2.222.223.32.731.421.26
Currency Exchange Gain (Loss)
2.222.22-3.79-0.96-1.69-1
Other Non Operating Income (Expenses)
-0.39-0-0---0
EBT Excluding Unusual Items
-164.61-171.55-285.66-179.68-131.67-96.7
Gain (Loss) on Sale of Assets
---0.02-0.01--
Pretax Income
-164.61-171.55-285.67-179.68-131.67-96.7
Income Tax Expense
-0.09-0.1-0.15-0.02--
Net Income
-164.51-171.44-285.52-179.67-131.67-96.7
Net Income to Common
-164.51-171.44-285.52-179.67-131.67-96.7
Shares Outstanding (Basic)
403833272119
Shares Outstanding (Diluted)
403833272119
Shares Change (YoY)
14.44%16.04%24.61%26.21%9.53%11.77%
EPS (Basic)
-4.15-4.46-8.62-6.76-6.25-5.03
EPS (Diluted)
-4.16-4.46-8.62-6.76-6.25-5.03
Free Cash Flow
-157.51-193.16-226.75-205.97-134.65-52.92
Free Cash Flow Per Share
-3.98-5.02-6.84-7.75-6.39-2.75
Gross Margin
100.00%100.00%----
Operating Margin
-13745.50%-6453.12%----
Profit Margin
-14942.23%-6952.27%----
Free Cash Flow Margin
-14306.08%-7833.05%----
EBITDA
-148.78-156.54-277.76-174.27-123.04-89.07
D&A For EBITDA
2.562.595.486.498.347.89
EBIT
-151.34-159.13-283.24-180.77-131.38-96.95
Source: S&P Global Market Intelligence. Standard template. Financial Sources.